Published in J Periodontol on April 01, 2003
Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin. J Inflamm (Lond) (2010) 0.82
Cyclosporin A reduces matrix metalloproteinases and collagen expression in dermal fibroblasts from regenerative FOXN1 deficient (nude) mice. Fibrogenesis Tissue Repair (2013) 0.78
Alport syndrome: significance of gingival biopsy in the initial diagnosis and periodontal evaluation after renal transplantation. J Appl Oral Sci (2009) 0.75
Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion. Br J Pharmacol (2017) 0.75
Efficacy of azithromycin and metronidazole combined therapy on rats' gingival overgrowth induced by cyclosporine-A: An experimental animal study. J Oral Biol Craniofac Res (2016) 0.75
Human odontoblasts express functional thermo-sensitive TRP channels: implications for dentin sensitivity. Pain (2010) 1.61
Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther (2005) 1.37
Regulation of HGF and SDF-1 expression by oral fibroblasts--implications for invasion of oral cancer. Oral Oncol (2007) 1.16
Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J Neuroimmunol (2008) 1.08
Dentine hypersensitivity in Jordanian dental attenders. A case control study. J Clin Periodontol (2002) 0.98
Tooth loss during maintenance following periodontal treatment in a periodontal practice in Norway. J Clin Periodontol (2004) 0.97
Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis Res Ther (2006) 0.97
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One (2011) 0.95
Identification and overexpression of human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue. Oral Oncol (2004) 0.91
Sarcoidosis with gingival involvement: a case report. J Periodontol (2004) 0.90
Patient perceptions of periodontal therapy completed in a periodontal practice. J Periodontol (2002) 0.90
Angiographically confirmed coronary heart disease and periodontal disease in middle-aged males. J Periodontol (2006) 0.89
Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients. Am J Physiol Lung Cell Mol Physiol (2008) 0.89
Phenotypic differences between oral and skin fibroblasts in wound contraction and growth factor expression. Wound Repair Regen (2006) 0.87
The lifetime direct cost of periodontal treatment: a case study from a Norwegian specialist practice. J Periodontol (2012) 0.87
The role of soluble interleukin (IL)-6 receptor in mediating the effects of IL-6 on matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression by gingival fibroblasts. J Periodontol (2002) 0.87
Quantitative analysis of substance P, neurokinin A and calcitonin gene-related peptide in gingival crevicular fluid associated with painful human teeth. Eur J Oral Sci (2002) 0.85
Human dental pulp fibroblasts express the "cold-sensing" transient receptor potential channels TRPA1 and TRPM8. J Endod (2011) 0.85
Substance P expression by human dental pulp fibroblasts: a potential role in neurogenic inflammation. J Endod (2009) 0.84
The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. Oral Oncol (2006) 0.84
The effects of cigarette smoking on the periodontal condition of young Jordanian adults. J Clin Periodontol (2003) 0.83
Replication of the association of chromosomal region 9p21.3 with generalized aggressive periodontitis (gAgP) using an independent case-control cohort. BMC Med Genet (2010) 0.82
Polymorphisms of TLR4 but not CD14 are associated with a decreased risk of aggressive periodontitis. J Clin Periodontol (2007) 0.81
Neuropeptides regulate expression of angiogenic growth factors in human dental pulp fibroblasts. J Endod (2009) 0.80
Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells. J Heart Lung Transplant (2008) 0.80
Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges. Mol Immunol (2007) 0.80
Compliance in a Norwegian periodontal practice. Oral Health Prev Dent (2003) 0.79
Mapping biological to clinical phenotypes during the development (21 days) and resolution (21 days) of experimental gingivitis. J Clin Periodontol (2011) 0.79
LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid. J Clin Periodontol (2013) 0.79
Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease. Arch Oral Biol (2008) 0.78
Caries-induced changes in the expression of pulpal neuropeptide Y. Eur J Oral Sci (2006) 0.77
Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts. Thorax (2007) 0.77
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma. Br J Haematol (2013) 0.77
Replication of the association of GLT6D1 with aggressive periodontitis in a Sudanese population. J Clin Periodontol (2015) 0.76
Long-term outcomes for cross-arch stabilizing bridges in periodontal maintenance patients--a retrospective study. J Clin Periodontol (2010) 0.75
Vasoactive intestinal polypeptide (VIP) and VPAC1 receptor in adult human dental pulp in relation to caries. Arch Oral Biol (2006) 0.75
Re-treatment profiles during long-term maintenance therapy in a periodontal practice in Norway. J Clin Periodontol (2005) 0.75
Gingival Inflammation and Aggressive Periodontitis in a Child with a Specific Antibody Deficiency. Dent Update (2016) 0.75
Incorporating severity and risk as factors to the Fardal cost-effectiveness model to create a cost-benefit model for periodontal treatment. J Periodontol (2013) 0.75
Hospital performance with myocardial reperfusion therapy: are hospitals capable of meeting established guidelines? Crit Pathw Cardiol (2003) 0.75